Search

everythinglearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Male hair loss is mainly due to thinner hair, not less hair.

The combination treatment showed a higher response rate but no significant survival benefits.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

New cancer drugs often cause skin and nail problems.

The combination of encorafenib and binimetinib caused few skin issues.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Cancer treatments often cause skin, nail, and hair problems.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Moles may stop growing because of cell cooperation, not just because of aging cells.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.